LAUREN CAMPISANO: Open Payments
NPI 1104316934 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 49 payments from 16 companies in 2025. Trend: 2023 $1,538 · 2024 $742 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $164 |
| Arcutis Biotherapeutics, Inc. | 6 | $99 |
| Incyte Corporation | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Amgen Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $34 |
Products named: SKYRIZI, Zoryve, DUPIXENT, OPZELURA, TALTZ, CIBINQO, COSENTYX, OTEZLA.
Industry payments across NJ — which companies pay providers there.
